EUVIMEDEUVIMED entdecken
Crossref

Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes

Marina Jara Vidal, Javier Torres Hernández, Marta Gallach Martínez, Andrés Ruíz de Assín Valverde, Laura Navarro Casado, Pedro J Pinés Corrales

Medicina Clínica · 2025

DOI: 10.1016/j.medcli.2025.106981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2025. Verfasst von Marina Jara Vidal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Albacete University Hospital Complex, Spain. Hauptthemen laut MEDLINE: Liver Cirrhosis, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: One of the most important emerging complications associated with diabetes is the Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD). The liver fibrosis index-4 (FIB-4) is proposed, as a first approach, to screening for cirrhosis in these patients. PATIENTS AND METHODS: All unique patients attended by diabetes in the EDN department of our hospital from 1 January 2022 to 31 December 2022 were included. The FIB-4 value for each patient was obtained retrospectively from the laboratory programme of our hospital. RESULTS: 1259 unique patients with type 2 diabetes were attended, and the prevalence of advanced FIB-4 in these patients was 4.77% [95%CI: 3.66-6.09%]. 580 unique patients with type 1 diabetes were attended, and the prevalence of advanced FIB-4 in these patients was 1.72% [95%CI: 0.83-3.15%]. DISCUSSION: Our study confirms the importance of FIB-4 in people with diabetes to identify patients at higher risk of advanced liver fibrosis. We must highlight that 10.9% of patients with type 2 diabetes and 9.5% of patients with type 1 diabetes had an indeterminate FIB-4 result.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1HumansMaleFemaleMiddle AgedRetrospective StudiesPrevalenceAdultAgedSeverity of Illness Index

Stichwörter der Autor:innen

Cirrosis hepáticaDiabetes mellitusEnfermedad hepática grasa no alcohólicaLiver cirrhosisNon-alcoholic fatty liver disease

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Albacete University Hospital Complex, Spain.
  • Department of Clinical Analysis, Albacete University Hospital Complex, Spain.
  • Department of Endocrinology and Nutrition, Albacete University Hospital Complex, Spain; Albacete Faculty of Medicine, University of Castilla-La Mancha, Spain. Electronic address: pjpines@sescam.jccm.es.

Zitieren

APA

Jara Vidal, M., Torres Hernández, J., Gallach Martínez, M., Ruíz de Assín Valverde, A., Navarro Casado, L., & Pinés Corrales, P. J. (2025). Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.106981

Vancouver

Jara Vidal M, Torres Hernández J, Gallach Martínez M, Ruíz de Assín Valverde A, Navarro Casado L, Pinés Corrales PJ. Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica. 2025. doi:10.1016/j.medcli.2025.106981

BibTeX
@article{JaraVidal2025,
  author = {Jara Vidal, Marina and Torres Hernández, Javier and Gallach Martínez, Marta and Ruíz de Assín Valverde, Andrés and Navarro Casado, Laura and Pinés Corrales, Pedro J},
  title = {Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes},
  journal = {Medicina Clínica},
  year = {2025},
  doi = {10.1016/j.medcli.2025.106981}
}
Kostenlos starten →